Cellular actions of nociceptin: transduction mechanisms

被引:87
作者
Hawes, BE
Graziano, MP
Lambert, DG
机构
[1] Schering Plough Res Inst, CNS CV Dept, Kenilworth, NJ 07033 USA
[2] Univ Leicester, Leicester Royal Infirm, Dept Anaesthesia & Pain Management, Leicester LE1 5WW, Leics, England
关键词
nociceptin; nociceptin receptor; signal transduction; cAMP; MAP kinase; intracellular Ca2+; desensitization;
D O I
10.1016/S0196-9781(00)00232-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recent identification of the nociceptin receptor-nociceptin system and the description of its role in nociceptive processing has produced numerous investigative studies. A fundamental part of this research is to understand the cellular signaling events (i.e. the building blocks) upon which the pharmacology of this intriguing system is based. As anticipated, nociceptin receptor activation inhibits the formation of cAMP formation via a pertussis toxin-sensitive G-protein. This indicates that nociceptin receptor couples to the G(i)G(o) class of G-protein(s). However, there is now growing evidence for nociceptin activation of additional signaling pathways, including MAP kinase and phospholipase C/[Ca2+](i). These signaling events are discussed in this review. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:961 / 967
页数:7
相关论文
共 71 条
[1]  
ALBAS J, 1993, J BIOL CHEM, V268, P22235
[2]   Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin orphanin FQ [J].
Berger, H ;
Albrecht, E ;
Wallukat, G ;
Bienert, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (03) :555-558
[3]   SIGNAL-TRANSDUCTION VIA THE MAP KINASES - PROCEED AT YOUR OWN RSK [J].
BLENIS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5889-5892
[4]   Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids [J].
Butour, JL ;
Moisand, C ;
Mazarguil, H ;
Mollereau, C ;
Meunier, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (01) :97-103
[5]  
Buzas B, 1998, J NEUROCHEM, V71, P556
[6]   Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist [J].
Calo', G ;
Guerrini, R ;
Bigoni, R ;
Rizzi, A ;
Marzola, G ;
Okawa, H ;
Bianchi, C ;
Lambert, DG ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (06) :1183-1193
[7]  
Chan JSC, 1998, J NEUROCHEM, V71, P2203
[8]   Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: Activation of inhibitory G protein and homologous desensitization [J].
Cheng, ZJ ;
Fan, GH ;
Zhao, J ;
Zhang, Z ;
Wu, YL ;
Jiang, LZ ;
Zhu, Y ;
Pei, G ;
Ma, L .
NEUROREPORT, 1997, 8 (08) :1913-1918
[9]   Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro [J].
Connor, M ;
Vaughan, CW ;
Chieng, B ;
Christie, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (08) :1614-1618
[10]   The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line [J].
Connor, M ;
Yeo, A ;
Henderson, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :205-207